Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
Avallone G, Maronese CA, Zussino M, Muratori S, Ferrucci SM, Quaglino P, Manni E, Romanelli M, De Simone C, Foti C, Gargiulo L, Maione V, Calzavara-Pinton P, Bardazzi F, Piraccini BM, Antiga E, Rech G, Balestri R, Vezzoli P, Sena P, Esposito M, Fargnoli MC, Termini D, Valtellini L, Satta RR, Vassallo C, Provini A, Di Zenzo G, Campanati A, Caproni M, Cozzani E, Ribero S, Marzano AV; DUO—DUpilumab and Omalizumab in Bullous Pemphigoid Study Group.
Avallone G, et al.
J Dermatol. 2025 Jun;52(6):983-1000. doi: 10.1111/1346-8138.17742. Epub 2025 Apr 16.
J Dermatol. 2025.
PMID: 40237419
Free article.